This inventor holds 4 USPTO granted patents. Top assignee: The University of Texas System. Active years: 2000-2006.
Company Filing History:
Years Active: 2000-2006
Title: Kevin Berman: Innovator in Protein Kinase Research
Introduction
Kevin Berman is a notable inventor based in Dallas, TX (US). He has made significant contributions to the field of protein kinase research, holding a total of 4 patents. His work focuses on the development of compositions and methods that enhance the activity of specific mitogen-activated protein kinases.
Latest Patents
Among his latest patents is the invention related to TAO protein kinase polypeptides and methods of use therefor. This patent provides compositions and methods aimed at potentiating the activity of the mitogen-activated protein kinase p38. Specifically, it highlights the role of the mitogen-activated protein kinase kinase MEK6 and its variants that stimulate the phosphorylation of p38. These compounds have potential therapeutic applications for diseases associated with the p38 cascade and can be utilized to identify antibodies and other agents that modulate signal transduction via p38.
Career Highlights
Kevin Berman is affiliated with the University of Texas System, where he continues to advance his research in protein kinases. His innovative work has positioned him as a key figure in the scientific community, particularly in the study of signal transduction pathways.
Collaborations
He has collaborated with esteemed colleagues such as Zhu Chen and Melanie H Cobb, further enhancing the impact of his research through teamwork and shared expertise.
Conclusion
Kevin Berman's contributions to protein kinase research exemplify the importance of innovation in the scientific field. His patents and ongoing work continue to pave the way for advancements in therapeutic applications.